tailieunhanh - How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review

This study aims to examine current practices of modeling companion biomarkers when assessing the cost-effectiveness of targeted cancer therapies. It investigates the current methods in modeling the characteristics of companion diagnostics based on existing economic evaluations of biomarker-guided therapies in cancer. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN